James N. Kochenderfer

Also affiliated with National Cancer Institute, Center for Cancer Research

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 23 papers. Top paper: “Transient responses and significant toxicities of anti-CD30 CAR T cells for CD30+ lymphomas: results of a phase 1 trial”.

Transient responses and significant toxicities of anti-CD30 CAR T cells for CD30+ lymphomas: results of a phase 1 trial

Blood Advances(2023)10.1182/bloodadvances.2023011470

N/A

1.1DataRank · unranked

31 citations

Danielle Natrakul, Jeremiah Karrs, Nisha Patel, Roberto Maass‐Moreno, Mark A. Ahlman +9 more

Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma

Nature Medicine(2020)10.1038/s41591-019-0737-3

N/A

0.865DataRank · unranked

318 citations

Norris Lam, Danielle Vanasse, Yueh-wei Shen, Jeremy J. Rose, John M. Rossi +15 more

The chimeric antigen receptor-intensive care unit (CAR-ICU) initiative: Surveying intensive care unit practices in the management of CAR T-cell associated toxicities

Journal of Critical Care(2020)10.1016/j.jcrc.2020.04.008

N/A

0.604DataRank · unranked

55 citations

Anne Rain Brown, Megan M. Herr, Sameer S. Kadri, Brian T. Hill, Prabalini Rajendram +22 more

Rapid anti-myeloma activity by T cells expressing an anti-BCMA CAR with a human heavy-chain-only antigen-binding domain

Molecular Therapy(2023)10.1016/j.ymthe.2023.12.018

N/A

0.590DataRank · unranked

15 citations

Danielle Natrakul, Norris Lam, Elisabet E. Manasanch, Jennifer Mann, Katherine A. Weissler +20 more

Replication competent retrovirus testing (RCR) in the National Gene Vector Biorepository: No evidence of RCR in 1,595 post-treatment peripheral blood samples obtained from 60 clinical trials

Molecular Therapy(2022)10.1016/j.ymthe.2022.12.006

N/A

0.475DataRank · unranked

11 citations

Jing Yao, Kimberley House, Lisa Duffy, Prasad S. Adusumilli, Rachel K. Beyer +26 more

Durable remissions in two adult patients with Burkitt lymphoma following anti-CD19 CAR T-cell therapy: a single center experience

Leukemia & lymphoma/Leukemia and lymphoma(2022)10.1080/10428194.2022.2076853

N/A

0.396DataRank · unranked

13 citations

Paul H. McClelland, Mark A. Ahlman, Stephanie L. Goff, James C. Yang, Lori McIntyre +4 more

Limited utility of chimeric antigen receptor (CAR) T-cell retreatment: experience with a human anti-CD19 CAR

Bone Marrow Transplantation(2023)10.1038/s41409-023-02041-0

N/A

0.165DataRank · unranked

2 citations

James N. Kochenderfer, Jennifer N. Brudno

Genome-wide profiling of retroviral DNA integration and its effect on clinical pre-infusion CAR T-cell products

Journal of Translational Medicine(2022)10.1186/s12967-022-03729-5

N/A

0DataRank · unranked

51 citations

Rongye Shi, Yingdong Zhao, Hui Liu, Alexander Lu, Jinxia Ma +13 more

The impact of race, ethnicity, and obesity on CAR T-cell therapy outcomes

Blood Advances(2022)10.1182/bloodadvances.2022007676

N/A

0DataRank · unranked

48 citations

John A. Ligon, Paul Borgman, Seth M. Steinberg, Toni Foley, Lauren Little +10 more

Acute and delayed cytopenias following CAR T-cell therapy: an investigation of risk factors and mechanisms

Leukemia & lymphoma/Leukemia and lymphoma(2022)10.1080/10428194.2022.2056172

N/A

0DataRank · unranked

45 citations

Danielle Natrakul, Norris Lam, Alina Dulau‐Florea, Constance M. Yuan, James N. Kochenderfer +1 more

Circulating CD22+/CD19−/CD24− progenitors and CD22+/CD19+/CD24− mature B cells: Diagnostic pitfalls for minimal residual disease detection in B‐lymphoblastic leukemia

Cytometry Part B Clinical Cytometry(2022)10.1002/cyto.b.22104

N/A

0DataRank · unranked

9 citations

Jeremiah Karrs, Truc Ho, Alyssa Doverte, James N. Kochenderfer, Nirali N. Shah +3 more

Development of a bicistronic anti-CD19/CD20 CAR construct including abrogation of unexpected nucleic acid sequence deletions

Molecular Therapy — Oncolytics(2023)10.1016/j.omto.2023.07.001

N/A

0DataRank · unranked

21 citations

Richard Finney, Shicheng Yang, Stephanie Choi, Xiaolin Wu, Lauren C. Cutmore +6 more

Crystal Structure of a Chimeric Antigen Receptor (CAR) scFv Domain Rearrangement Forming a VL-VL Dimer

Crystals(2023)10.3390/cryst13040710

N/A

0DataRank · unranked

8 citations

Shagun Wazir, David R. Bell, James N. Kochenderfer, Wayne A. Hendrickson, Philippe Youkharibache +1 more

Current understanding and management of CAR T cell-associated toxicities

Nature Reviews Clinical Oncology(2024)10.1038/s41571-024-00903-0

N/A

0DataRank · unranked

244 citations

James N. Kochenderfer, Jennifer N. Brudno

Chimeric antigen receptor T cell therapy for autoimmune disease

Nature reviews. Immunology(2024)10.1038/s41577-024-01035-3

N/A

0DataRank · unranked

126 citations

Jennifer N. Brudno, Dominic Borie, James N. Kochenderfer, James Chung

Optimization of anti-CD19 CAR T cell production for treatment of patients with chronic lymphocytic leukemia

Molecular Therapy — Methods & Clinical Development(2024)10.1016/j.omtm.2024.101212

N/A

0DataRank · unranked

6 citations

Katherine A. Weissler, Vicki Fellowes, Norris Lam, Lauren C. Cutmore, Danielle Natrakul +3 more

Survival after anti-CD19 CAR T-cell therapy for B-cell non-Hodgkin lymphoma and CLL with 10 years of follow-up

Blood Advances(2025)10.1182/bloodadvances.2025016504

N/A

0DataRank · unranked

1 citations

Lori McIntyre, Stephanie L. Goff, James C. Yang, Danielle Natrakul, Steven A. Rosenberg +3 more

Anti-BCMA chimeric antigen receptors with fully human heavy-chain-only antigen recognition domains

Nature Communications(2020)10.1038/s41467-019-14119-9

N/A

0DataRank · unranked

125 citations

Nathan D. Trinklein, Benjamin Buelow, George H. Patterson, Namrata Ojha, James N. Kochenderfer +1 more

Development of CAR T Cells Expressing a Suicide Gene Plus a Chimeric Antigen Receptor Targeting Signaling Lymphocytic-Activation Molecule F7

Molecular Therapy(2020)10.1016/j.ymthe.2020.10.008

N/A

0DataRank · unranked

101 citations

Melissa A. Pegues, Norris Lam, Danielle Vanasse, Claudia Geldres, Stephanie Choi +4 more

Author Correction: Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma

Nature Medicine(2020)10.1038/s41591-020-0864-x

N/A

0DataRank · unranked

4 citations

Norris Lam, Danielle Vanasse, Yueh-wei Shen, Jeremy J. Rose, John M. Rossi +15 more

Long-term follow-up of anti-CD19 CAR T-cell therapy for B-cell lymphoma and chronic lymphocytic leukemia.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.3012

N/A

0DataRank · unranked

4 citations

Richard M. Sherry, James C. Yang, Stephanie L. Goff, Danielle Vanasse, Lori McIntyre +3 more

Yearlong COVID-19 Infection Reveals Within-Host Evolution of SARS-CoV-2 in a Patient With B-Cell Depletion

The Journal of Infectious Diseases(2021)10.1093/infdis/jiab622

N/A

0DataRank · unranked

93 citations

Allison Roder, Sanchita Basu Das, Emmie de Wit, Jung-Ho Youn, Stephanie Banakis +10 more

Infectious complications of CAR T-cell therapy across novel antigen targets in the first 30 days

Blood Advances(2021)10.1182/bloodadvances.2021004896

N/A

0DataRank · unranked

73 citations

Bonnie Yates, Seth M. Steinberg, Shilpa Shahani, John C. Molina, Tara N. Palmore +10 more